C. Baba Et Al. , "Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies," Multiple Sclerosis and Related Disorders , vol.68, 2022
Baba, C. Et Al. 2022. Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies. Multiple Sclerosis and Related Disorders , vol.68 .
Baba, C., ÖZÇELİK, S., KAYA, E., Samedzada, U., Ozdogar, A. T., Cevik, S., ... DOĞAN, Y.(2022). Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies. Multiple Sclerosis and Related Disorders , vol.68.
Baba, Cavid Et Al. "Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies," Multiple Sclerosis and Related Disorders , vol.68, 2022
Baba, Cavid Et Al. "Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies." Multiple Sclerosis and Related Disorders , vol.68, 2022
Baba, C. Et Al. (2022) . "Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies." Multiple Sclerosis and Related Disorders , vol.68.
@article{article, author={Cavid Baba Et Al. }, title={Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies}, journal={Multiple Sclerosis and Related Disorders}, year=2022}